A potential harmful effect of dexamethasone in non-severe COVID-19: results from the COPPER-pilot study

This study suggests caution when prescribing systemic corticosteroids to patients with #COVID19 who show mild-to-moderate pulmonary symptoms because a harmful effect cannot be excluded https://bit.ly/3P4nOjQ

Detalles Bibliográficos
Autores principales: Kocks, Janwillem, Kerkhof, Marjan, Scherpenisse, Jan, van de Maat, Aimée, van Geer-Postmus, Iris, le Rütte, Thomas, Schaart, Jan, Gans, Reinold O.B., Kerstjens, Huib A.M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2022
Materias:
Research Letters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9131124/
https://www.ncbi.nlm.nih.gov/pubmed/35642194
http://dx.doi.org/10.1183/23120541.00129-2022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9131124/
https://www.ncbi.nlm.nih.gov/pubmed/35642194
http://dx.doi.org/10.1183/23120541.00129-2022

Ejemplares similares